Filing Details
- Accession Number:
- 0001181431-13-003638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-17 16:10:33
- Reporting Period:
- 2013-01-15
- Filing Date:
- 2013-01-17
- Accepted Time:
- 2013-01-17 16:10:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1135906 | Zalicus Inc. | ZLCS | Pharmaceutical Preparations (2834) | 043514457 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1250661 | Mark Corrigan | C/O Zalicus Inc. 245 First Street, 3Rd Floor Cambridge MA 02142 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-01-15 | 112,850 | $0.77 | 844,090 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported by this form were to satisfy statutory tax withholding requirements upon vesting of restricted stock units.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.74. The reporting person untertakes to provide to Zalicus Inc., any security holder of Zalicus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2 to this Form 4.
Billionaire Hedge Funds
